drugset / Trial / NCT06087237
The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this clinical trial is to assess the efficacy of pentoxifylline in reducing postsurgical complications for breast cancer patients undergoing breast cancer surgery. It aims to evaluate the efficacy of pentoxifylline on postoperative pain and wound healing.
Timeline
- Start
- 2023-10-30
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | Oral |
| Comparator | Acetaminophen | Small molecule | 1 g | Intravenous |
| Comparator | Ketorolac | Other / unclassified | 30 mg | Intravenous |